Charles E. Alpers
Impact in
- Nephrology top 0.01%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments
Papers in
- Nephrology 212
- Renal Diseases and Glomerulopathies 179
- Chronic Kidney Disease and Diabetes 73
- Rheumatology 62
- Systemic Lupus Erythematosus Research 36
- Co-authors
- Richard J. Johnson (47 shared papers)Kelly L. Hudkins (102 shared papers)William G. Couser (35 shared papers)Kevin D. O’Brien (11 shared papers)Agnes B. Fogo (106 shared papers)Jürgen Floege (16 shared papers)P Pritzl (11 shared papers)Cecilia M. Giachelli (12 shared papers)
- Journals
- American Journal of Kidney Diseases (114 papers)Kidney International (74 papers)Journal of the American Society of Nephrology (37 papers)Clinical Journal of the American Society of Nephrology (10 papers)American Journal of Physiology-Renal Physiology (10 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Charles E. Alpers
453 papers receiving 34.8k citations
Charles E. Alpers's Hit Papers
Peers
Comparison fields: 5 of 172
- Nephrology 13.2k
- Transplantation 1.2k
- Rheumatology 5.4k
- Immunology and Allergy 1.6k
- Immunology 5.7k
Countries citing papers authored by Charles E. Alpers
This map shows the geographic impact of Charles E. Alpers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Alpers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Alpers more than expected).
Fields of papers citing papers by Charles E. Alpers
This network shows the impact of papers produced by Charles E. Alpers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Alpers. The network helps show where Charles E. Alpers may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles E. Alpers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 464 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited Hit paper breakdown → | 2004 | 1632 |
| 2 | The classification of glomerulonephritis in systemic lupus erythematosus revisited Hit paper breakdown → | 2004 | 1313 |
| 3 | VEGF Inhibition and Renal Thrombotic Microangiopathy Hit paper breakdown → | 2008 | 1274 |
| 4 | Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group Hit paper breakdown → | 2017 | 885 |
| 5 | The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility Hit paper breakdown → | 2009 | 859 |
| 6 | Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices Hit paper breakdown → | 2018 | 746 |
| 7 | Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection Hit paper breakdown → | 1993 | 742 |
| 8 | Mouse Models of Diabetic Nephropathy Hit paper breakdown → | 2009 | 729 |
| 9 | Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. Hit paper breakdown → | 1993 | 585 |
| 10 | 1996 | 495 | |
| 11 | C3 glomerulopathy: consensus report Hit paper breakdown → | 2013 | 493 |
| 12 | Renal injury from angiotensin II-mediated hypertension. Hit paper breakdown → | 1992 | 484 |
| 13 | Molecular mechanisms and therapeutic targets for diabetic kidney disease Hit paper breakdown → | 2022 | 457 |
| 14 | 1996 | 455 | |
| 15 | 1991 | 430 | |
| 16 | An atlas of healthy and injured cell states and niches in the human kidney Hit paper breakdown → | 2023 | 394 |
| 17 | 1995 | 369 | |
| 18 | 1992 | 368 | |
| 19 | 1995 | 333 | |
| 20 | 1992 | 316 |
About Charles E. Alpers
Charles E. Alpers is a scholar working on Nephrology, Rheumatology, Immunology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 464 papers that have together received 35.9k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (179 papers), Chronic Kidney Disease and Diabetes (73 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (39 papers), Systemic Lupus Erythematosus Research (36 papers), Complement system in diseases (31 papers), Renal and Vascular Pathologies (23 papers), Renal and related cancers (21 papers) and Cell Adhesion Molecules Research (20 papers). The work is most often cited by research in Nephrology (13.2k citations), Transplantation (1.2k citations), Rheumatology (5.4k citations), Immunology and Allergy (1.6k citations) and Immunology (5.7k citations). Charles E. Alpers has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Richard J. Johnson, Kelly L. Hudkins, William G. Couser, Kevin D. O’Brien, Agnes B. Fogo, Jürgen Floege, P Pritzl, Cecilia M. Giachelli, KATHERINE L. GORDON and Stuart J. Shankland. Their work appears in journals such as American Journal of Kidney Diseases, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology and American Journal of Physiology-Renal Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.